Skip to main content
NIH funding notice PAR-23-042

Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional)

Closed on March 9, 2023.

Posted
December 7, 2022
Close date
March 9, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,282,564 in first-year total cost, median $641,282.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 HSS-P (50)]2

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
  2. UNIVERSITY OF TEXAS AT AUSTIN1
Competing awards under PAR-23-042 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Scaling Up Community-based Noncommunicable Disease Research into Practice in Pokhara Metropolitan City of Nepal (SCALE-NCD)1R01HL172271-01NEUPANE, DINESHJOHNS HOPKINS UNIVERSITY, MD$657,262ZRG1
2024Contextually responsive implementation of place-activation interventions for promoting physical activity in marginalized urban peripheries in Mexico1R01MD019155-01SALVO, DEBORAHUNIVERSITY OF TEXAS AT AUSTIN, TX$625,302ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.